by jstep8856 | March 11, 2014 4:20 pm
Hello Travis
Just saw a teaser about a ”Boston Biotech” stock that is poised to show 400 to 700% profits this year from Penny Stock gurus Manny Backus[1]. Can you ”thinkolate” this one. Sounds pretty promising!
Thanks for your thoughts. They’re always appreciated!
Source URL: https://www.stockgumshoe.com/2014/03/microblog-looking-for-info-on-manny-backus-boston-biotech-stock/
Copyright ©2024 Stock Gumshoe unless otherwise noted.
Also have seen this one a lot..would love to know the ticker!
Paul ,try BSX Boston scientific. I have seen that teased before but I don’t know of ant new developments..
Could be ZIOPHARM;
http://seekingalpha.com/author/manny-backus/articles
Jeff,
Greenfire67 is 100% correct on Ziopharm. Manny Backus wrote up a major article
December 15, 2013 on it which you can read. He was promoting this stock on his Conscensus Picks which I still subscribe to. At that time he was advising subscribers
to buy below $4 and to sell at $9. The drug in question is AD-RTS-IL-12 which is in
phase two trials as of December 15, 2013. Also, the two partners that Ziopharm
is working with are Intrexon (XON) and Mesoblast. The insider guy in the tease that
bought 2,8577,000 shares for a cool ten million is Randall Kirk. They also issued 14.3 million shares last March which caused shares to plummet to $3.50 a stub. The title
of the article is “Ziopharm: Finally a Cure in the War on Cancer?” which you can access
by typing in ZIOP on the Finviz site, and scrolling down for this article below the stock
chart. I’m not sure but Dr. Karma might have something to say about it in the Benitech
blog.